NDC 60505-2656-01 - Triamterene and Hydrochlorothiazide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 60505-2656
- Requested NDC
- 60505-2656-01
- Package NDCs from labels
- 60505-2656-1, 60505-2656-5, 60505-2656-7, 60505-2656-01
- Manufacturer
- PD-Rx Pharmaceuticals, Inc.
- Effective date
- 2026-07-08
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Triamterene and Hydrochlorothiazide Tablets, 37.5 mg/ 25 mg | PD-Rx Pharmaceuticals, Inc. | 2026-07-08 | HUMAN PRESCRIPTION DRUG LABEL |
| Triamterene and Hydrochlorothiazide Tablets, 37.5 mg/ 25 mg and 75 mg/50 mg | Apotex Corp. | Apotex Inc. | 2026-02-17 | HUMAN PRESCRIPTION DRUG LABEL |
| Triamterene and Hydrochlorothiazide Tablets, 37.5 mg/ 25 mg | Golden State Medical Supply, Inc. | 2026-02-12 | HUMAN PRESCRIPTION DRUG LABEL |
| Triamterene and Hydrochlorothiazide - Northwind Health Company, LLC | Northwind Health Company, LLC | 2026-01-01 | HUMAN PRESCRIPTION DRUG LABEL |
| Triamterene and Hydrochlorothiazide - Bryant Ranch Prepack | Bryant Ranch Prepack | 2025-09-12 | HUMAN PRESCRIPTION DRUG LABEL |
| Triamterene and Hydrochlorothiazide - American Health Packaging | American Health Packaging | 2025-01-08 | HUMAN PRESCRIPTION DRUG LABEL |
| Triamterene and Hydrochlorothiazide Tablets, 37.5 mg/ 25 mg and 75 mg/50 mg | Preferred Pharmaceuticals Inc. | 2024-08-21 | HUMAN PRESCRIPTION DRUG LABEL |
| Triamterene and Hydrochlorothiazide Tablets, 37.5 mg/ 25 mg and 75 mg/50 mg | RPK Pharmaceuticals, Inc. | 2023-06-07 | HUMAN PRESCRIPTION DRUG LABEL |
| Triamterene and Hydrochlorothiazide Tablets, 37.5 mg/ 25 mg and 75 mg/50 mg | REMEDYREPACK INC. | 2023-02-21 | HUMAN PRESCRIPTION DRUG LABEL |
| Triamterene and Hydrochlorothiazide - AvKARE | AvKARE | 2022-01-17 | HUMAN PRESCRIPTION DRUG LABEL |
| Triamterene and Hydrochlorothiazide - Aphena Pharma Solutions - Tennessee, LLC | Aphena Pharma Solutions - Tennessee, LLC | 2021-11-05 | HUMAN PRESCRIPTION DRUG LABEL |
| TRIAMTERENE AND HYDROCHLOROTHIAZIDE - DirectRX | DirectRX | 2021-07-26 | HUMAN PRESCRIPTION DRUG LABEL |
| Triamterene and Hydrochlorothiazide - A-S Medication Solutions | A-S Medication Solutions | 2021-04-14 | HUMAN PRESCRIPTION DRUG LABEL |
| Triamterene and Hydrochlorothiazide Tablets, 37.5 mg/ 25 mg and 75 mg/50 mg | NuCare Pharmaceuticals,Inc. | 2021-02-11 | HUMAN PRESCRIPTION DRUG LABEL |
| LACTOSE MONOHYDRATE - Denton Pharma, Inc. DBA Northwind Pharmaceuticals | Denton Pharma, Inc. DBA Northwind Pharmaceuticals | 2019-10-22 | HUMAN PRESCRIPTION DRUG LABEL |
| Triamterene and Hydrochlorothiazide Tablets, 37.5 mg/ 25 mg | Preferred Pharmaceuticals, Inc. | 2016-09-15 | HUMAN PRESCRIPTION DRUG LABEL |
| Triamterene and Hydrochlorothiazide - State of Florida DOH Central Pharmacy | State of Florida DOH Central Pharmacy | 2014-04-24 | HUMAN PRESCRIPTION DRUG LABEL |
| Triamterene and Hydrochlorothiazide - Aidarex Pharmaceuticals LLC | Aidarex Pharmaceuticals LLC | 2014-02-02 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 60505-2656-1 | Triamterene and Hydrochlorothiazide | 100 in 1 BOTTLE | TABLET | 100 | 10 | |
| 60505-2656-5 | Triamterene and Hydrochlorothiazide | 500 in 1 BOTTLE | TABLET | 500 | 10 | |
| 60505-2656-7 | Triamterene and Hydrochlorothiazide | 6500 in 1 BOTTLE | TABLET | 6500 | 10 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 60505-2656 | TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [APOTEX CORP.] | 7 | Current NDC, Legacy NDC, 3 package rows | 20241004_bd6c3495-ec70-908b-482a-a979506659e9.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 60505-2656-1 | EA - Each | 60505-2656 | 5c28cf4c-512f-45f9-ae8e-73dc51812630 | 1 | 2012-07-24 |
| 60505-2656-5 | EA - Each | 60505-2656 | 795b59e4-7e2e-4885-bdcd-64365ce7831e | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide | OLMESARTAN MEDOXOMIL / AMLODIPINE BESYLATE / HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 57ffeef7-bfa8-4f92-aadc-23cd00022607 | 2026-10-19 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Preferred Pharmaceuticals Inc. | 5fc69fbf-c2d2-41ef-99bb-62a76ef74db2 | 2026-10-19 | Boxed warning, Warnings, Adverse reactions | 310818 WS821Z52LQ 0J48LPH2TH |
| Telmisartan and Hydrochlorothiazide | TELMISARTAN AND HYDROCHLOROTHIAZIDE | Aurobindo Pharma Limited | 681dfb5c-fc5c-427e-81f6-4b4e934978a2 | 2026-10-16 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | REMEDYREPACK INC. | 3bea11a3-eb07-46b2-9b91-f8a48a2f3b7e | 2026-10-12 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 31a3d1cb-0f52-4818-965d-7584374bb23e | 2026-10-12 | Warnings, Adverse reactions | 0J48LPH2TH |
| LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Granules Pharmaceuticals Inc. | b4168479-09ec-402c-89cc-456bc8485017 | 2026-10-08 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Advagen Pharma Ltd | f4b10352-a923-4713-9d33-8f3636941b2e | 2026-10-08 | Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | NuCare Pharmaceuticals,Inc. | 8bc8d5e2-a974-64ed-e053-2a95a90a8340 | 2026-10-08 | Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | St. Mary's Medical Park Pharmacy | 00b266d9-ac4a-e931-e063-6294a90a6a0b | 2026-10-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Westminster Pharmaceuticals, LLC | 0fc94bc2-fa38-439a-a609-1b4130cdacb1 | 2026-09-29 | Warnings, Adverse reactions | 0J48LPH2TH |
| OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | Ascend Laboratories, LLC | 798fee33-51ad-45d0-82f3-09289304139f | 2026-09-24 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Preferred Pharmaceuticals Inc. | b9b85048-5776-455f-bea6-6ab818cb8144 | 2026-09-24 | Warnings, Adverse reactions | 0J48LPH2TH |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 2dd7c2a4-d335-4c6f-b1e6-b0ae6eebab84 | 2026-09-23 | Warnings, Adverse reactions | 0J48LPH2TH |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Zydus Lifesciences Limited | e92f1118-8eaf-4fa8-b167-1447550af1ab | 2026-09-18 | Boxed warning, Adverse reactions | WS821Z52LQ 0J48LPH2TH |
| Bisoprolol Fumarate and Hydrochlorothiazide | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | Aurobindo Pharma Limited | 2db1a899-f115-4da5-89fe-6e5b41086f6c | 2026-09-18 | Warnings, Adverse reactions | 0J48LPH2TH |
| VALSARTAN AND HYDROCHLOROTHIAZIDE | VALSARTAN AND HYDROCHLOROTHIAZIDE | Golden State Medical Supply, Inc. | 5ba10848-9a4c-1a28-e063-6394a90ab047 | 2026-09-16 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | Aphena Pharma Solutions - Tennessee, LLC | 5ba2325f-5fc1-f6f0-e063-6294a90aefc6 | 2026-09-16 | Warnings, Adverse reactions | 0J48LPH2TH |
| Metoprolol Tartrate and Hydrochlorothiazide | METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE | Mylan Pharmaceuticals Inc. | b6cf0f43-8dc3-4535-b651-daf1f9e0336c | 2026-09-15 | Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | REMEDYREPACK INC. | d383e0e5-4e00-44cc-9d6f-86e76f4e79e3 | 2026-09-15 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 206cd386-cf38-4e0f-80ec-685aea41b048 | 2026-09-15 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.